Icon’s impressive capabilities have attracted large pharmaceutical clients, including a preferred partnership with Pfizer. Historically, Icon's revenue heavily relied on Pfizer, its largest customer, ...
Icon ICLR reported solid third-quarter results, highlighted by revenue exceeding $2 billion, representing an increase of nearly 6% from the prior-year period. We continue to have a positive outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results